Published in Osteoporos Int on March 20, 2010
Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. Int J Clin Oncol (2013) 1.80
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res (2011) 1.32
Osteonecrosis of jaw associated with bisphosphonate use. Indian J Endocrinol Metab (2012) 0.97
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab. Ther Clin Risk Manag (2012) 0.97
Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility. Ther Clin Risk Manag (2012) 0.90
Evolving role of bone biomarkers in castration-resistant prostate cancer. Neoplasia (2010) 0.84
The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications. J Osteoporos (2011) 0.79
Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report. BMC Gastroenterol (2014) 0.78
Treatment of osteoporosis in renal insufficiency. Clin Rheumatol (2015) 0.76
New cancer therapies and jaw necrosis. Br Dent J (2015) 0.75
Bone health in nonmetastatic prostate cancer: what's the big deal? Curr Oncol (2010) 0.75
Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol (2009) 2.45
Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med (2008) 1.85
Risks and benefits of bisphosphonates. Br J Cancer (2008) 1.57
Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg (2010) 1.18
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol (2008) 1.10
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis. Horm Metab Res (2009) 0.97
Osteonecrosis of the jaw in patients receiving oral bisphosphonates. Osteoporos Int (2009) 0.89
Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Expert Rev Anticancer Ther (2009) 0.83
RANKL inhibition for the management of patients with benign metabolic bone disorders. Expert Opin Investig Drugs (2009) 0.82
"Fatigue" having a role in the pathogenesis of osteonecrosis of the jaws. Clin Oral Investig (2009) 0.76
Accuracy of dermoscopic criteria for the diagnosis of psoriasis, dermatitis, lichen planus and pityriasis rosea. Br J Dermatol (2012) 2.03
The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.13
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol (2012) 1.06
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis. Horm Metab Res (2009) 0.97
Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J Clin Pharm Ther (2010) 0.91
Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol (2009) 0.90
Thyroid diseases and female reproduction. Minerva Med (2012) 0.85
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma. Br J Dermatol (2014) 0.85
Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab. Osteoporos Int (2009) 0.84
Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding 'risks and benefits of bisphosphonates'. Br J Cancer (2008) 0.82
Peer review and journal impact factor: the two pillars of contemporary medical publishing. Hippokratia (2010) 0.81
A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice. Hippokratia (2010) 0.80
Long-term effects of thyroid fine-needle biopsy on the thyroid-related biochemical parameters. Int J Clin Pract (2012) 0.80
Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial. Int J Clin Pract (2012) 0.80
Dermoscopy uncovers clinically undetectable pigmentation in basal cell carcinoma. Br J Dermatol (2014) 0.77
Performance of the mini nutritional assessment score in the detection of vitamin D status in an elderly Greek population. Horm Metab Res (2012) 0.77
Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis. J Eur Acad Dermatol Venereol (2010) 0.77
Impact of diabetes on inpatient mortality and length of stay for elderly patients presenting with fracture of the proximal femur. J Diabetes Complications (2013) 0.76
Preoperative withdrawal of antiplatelet treatment in lower limb vascular patients prior to surgical management under epidural or spinal anaesthesia: an evidence based approach and systematic review. Int Angiol (2010) 0.76
A safe modality. Br Dent J (2009) 0.76
The role of dental hygienist in the prevention of osteonecrosis of the jaw in patients wearing dentures. Int J Dent Hyg (2010) 0.75
Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular events. J Eur Acad Dermatol Venereol (2013) 0.75
New evidence on bisphosphonate related osteonecrosis of the jaws suggests dental referral prior to commencement of treatment. Hippokratia (2009) 0.75
Methods and Biostatistics: a concise guide for peer reviewers. Hippokratia (2010) 0.75
Dermoscopic nevus patterns in skin of colour: a prospective, cross-sectional, morphological study in individuals with skin type V and VI. J Eur Acad Dermatol Venereol (2013) 0.75